TAT 2018: Programme

The 16th edition of the International Congress on Targeted Anticancer Therapies (TAT) will take place in Paris, 5-7 March 2018.

Access the TAT 2018 Online Programme

TAT 2018 focuses on early-phase development and translational research.

The programme, established by a prestigious Scientific Committee led jointly by G. Giaccone and J. Tabernero, will include Plenary sessions, Proffered Paper sessions and poster presentations by a number of international experts. Numerous targets will be presented and discussed including Immuno-, Epigenetic-, Metabolic-, Cell-cycle-, DNA-, PI3 Kinase-targets and others, as single agents or in combination.

The TAT congress and its programme is dedicated to a broad range of professionals including basic scientists, physicians and translational researchers from academic settings, industry and regulatory agencies interested in pre-clinical and early clinical development of targeted pathways. All stake-holders involved in cancer will find an opportunity at TAT 2018 for learning, discussing and networking in a very active scientific field where recent progress in knowledge has already translated into improvements in cancer patient outcome.